I had written a reply contradicting post #29 and deleted it. Here is what survived.
The documentation on widely repeated interaction claim is better than this thread and I say that as someone who has posted in the thread.
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
I had written a reply contradicting post #29 and deleted it. Here is what survived.
The documentation on widely repeated interaction claim is better than this thread and I say that as someone who has posted in the thread.
That is a cleaner way of putting what I was circling around.
Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you are on it; monitoring INR more frequently during weight loss is reasonable.
Post #33 is the version of this I will quote in future. One addition.
Second-hand on widely repeated interaction claim, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Research-use-only compounds have no interaction data of any kind, because interaction studies are done on medicines being developed for use in people.
Insulin and sulfonylureas are the interaction that the labelling in this class flags most explicitly, because the risk is additive glucose lowering. That is a prescribing question and not a forum question.
Absence of an interaction study is not evidence of no interaction. A great many combinations discussed here have simply never been studied, and saying so is more useful than reasoning from mechanism alone.
That has held every time I have looked, which is not the same as always.
Post #38 is right about the mechanism and I think understates the practical bit.
Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but that is a nutritional consequence rather than an interaction.
Widely repeated interaction claim is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes before adding to this one.
Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the conservative reading is the obvious one.
Worth reading the earlier posts in this thread before acting on mine.
Anyone asking an interaction question should list everything, including the things they consider irrelevant. The irrelevant one is the answer more often than chance would suggest.
I would hold that lightly until someone with a larger sample weighs in.
Agreed on widely repeated interaction claim, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the starting assumption is the part nobody states.
Post #44 and I disagree about the size of the effect, not about the direction.
A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is usually worse rather than better.
I had written a reply contradicting post #48 and deleted it. Here is what survived.
Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer.
Gastrointestinal symptoms from one compound can mask or mimic an interaction with another. Introducing two changes at once makes attribution impossible, which is an argument for spacing them.
Not disagreeing with anyone above, just adding the bit I keep having to look up.
Post #51 answers the question as asked. The question underneath it is different.
The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather than filling the gap.
It is worth stating the boring hypothesis before the interesting one.
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Follow-up: Oral contraceptives and delayed emptying: what the data shows
Oral contraceptives and delayed emptying: what the data shows — setting out what I have, and where I think it stops being reliable. A follow-up question about Oral contraceptives and delayed emptying that I…
|
+31 | 35 | 13k | 18mo |
|
Follow-up: Levothyroxine timing: a real interaction with a simple fix
On the subject in the title: Levothyroxine timing: a real interaction with a simple fix Working notes rather than a conclusion. A follow-up question about Levothyroxine timing that I did not know to ask the…
|
+2 | 6 | 8.1k | 4mo |
|
Oral contraceptives and delayed emptying: what the data shows
Posting this under the heading it deserves: Oral contraceptives and delayed emptying: what the data shows Everything below is what sits behind that. The question about oral contraceptives and delayed emptying…
|
+63 | 71 | 5.9k | 2y |
|
Alcohol: what is documented and what is folklore
Posting this under the heading it deserves: Alcohol: what is documented and what is folklore Everything below is what sits behind that. Alcohol, and specifically the version of it that the documentation does…
|
+120 | 134 | 11k | 2d |
|
About the Interactions category
Drug, supplement and food interactions — separating timing inconveniences from clinically important ones. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
|
+4 | 8 | 1.9k | 2mo |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Follow-up: Signs of dehydration worth acting on
Posting this under the heading it deserves: Signs of dehydration worth acting on Everything below is what sits behind that. A follow-up question about Signs of dehydration worth acting that I did not know to…
|
+35 | 39 | 9.8k | 1d |
|
Stability of BPC-157 in solution: what has been measured
Stability of BPC-157 in solution: what has been measured — setting out what I have, and where I think it stops being reliable. Something about stability of BPC-157 does not reconcile and I would like a second…
|
2 | 805 | 30d | |
|
Compounds this community declines to help with, and why
Compounds this community declines to help with, and why — setting out what I have, and where I think it stops being reliable. Putting the numbers in the first post, because a question about a compound without…
|
+81 | 87 | 35k | 10mo |
|
Anaesthesia and elective surgery: the aspiration question — does this still hold?
Anaesthesia and elective surgery: the aspiration question — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about Anaesthesia and…
|
+23 | 27 | 5.6k | 17mo |
|
Muscle cramps: the ordinary causes before the exotic ones — a second dataset
Posting this under the heading it deserves: Muscle cramps: the ordinary causes before the exotic ones — a second dataset Everything below is what sits behind that. Something about Muscle cramps does not…
|
+65 | 77 | 39k | 1d |